NCT02349399View on ClinicalTrials.gov

Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases

CompletedOBSERVATIONAL

Enrollment

26,065

Participants

Timeline

Start Date

May 1, 2015

Primary Completion Date

March 1, 2016

Study Completion Date

March 1, 2016

Conditions

Acne Vulgaris

Interventions

DRUG

Cyproterone / Ethinylestradiol (Diane-35, BAY86-5264) and its Generics

Hormonal Contraceptive: Cyproterone Acetate 2 mg / Ethinylestradiol 35 μg

Trial Locations (3)

Unknown

Many Locations

Many Locations

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY